No connection

Search Results

NVAX

NEUTRAL
$8.69 Live
Novavax, Inc. · NASDAQ
Target $14.0 (+61.1%)
$5.8 52W Range $11.97

At a glance

Key valuation, profitability, growth, and risk metrics.

Unlock key metrics

Market cap, P/E, ROE, margins, leverage and more.

AI Analysis

AI-powered fundamental assessment

Confidence
75%
NVAX presents a complex profile with a stable Piotroski F-Score of 5/9, yet it exhibits severe fundamental contradictions. While the stock trades at a significant discount to its growth-based intrinsic value of $18.69 and shows impressive YoY revenue growth of 66.6%, the negative Price/Book ratio (-11.06) indicates a deficit in shareholders' equity. The transition from a low trailing P/E (3.25) to a negative forward P/E (-8.57) suggests that recent profitability may be transient. Combined with a completely bearish technical trend (0/100), the stock is a high-risk speculative play despite analyst 'buy' recommendations.

Key Strengths

Strong YoY revenue growth of 66.60%
Significant discount to intrinsic value ($8.69 vs $18.69)
Healthy short-term liquidity with a Current Ratio of 2.13
Recent high profit margins (39.19%) and ROA (25.72%)
Positive analyst consensus with a target price of $14.00

Key Risks

Negative shareholders' equity as indicated by Price/Book of -11.06
Negative forward P/E suggests a return to losses
Extreme historical earnings volatility with massive misses and beats
Severe bearish technical trend (0/100)
Long-term value destruction (-96.2% 5-year change)
AI Fair Value Estimate
Based on comprehensive analysis
$13.69
+57.5% above current price

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

Sign up to view

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare NVAX against industry averages and similar companies

Unlock Sector Insights

See how NVAX compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

Past News Coverage

Recent headlines mentioning NVAX from our newsroom.

Newest → oldest

See the full NVAX analysis

Free signup • Unlock all metrics • No credit card required

TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile